Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lidocaine + ropivacaine is a combination of two amide-type local anesthetics used primarily for regional and local anesthesia, especially in surgical settings requiring prolonged analgesia. Lidocaine provides a rapid onset of anesthesia, while ropivacaine offers a longer duration of action with reduced cardiotoxicity compared to other long-acting agents. Both drugs act by blocking voltage-gated sodium channels on neuronal membranes, inhibiting the initiation and conduction of nerve impulses. This combination is often employed in procedures such as brachial plexus blocks or caudal anesthesia to achieve both quick onset and extended pain relief[1][4][5]. The mixture can be safely used for locoregional anesthesia where long surgical intervention time or improved postoperative analgesia is desired[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + ropivacaine.